Company Registration No. 10791545 (England and Wales)
Unium Bioscience Ltd
Unaudited accounts
for the year ended 31 December 2024
Unium Bioscience Ltd
Unaudited accounts
Contents
Unium Bioscience Ltd
Company Information
for the year ended 31 December 2024
Directors
Mr John Haywood
John Haywood
Company Number
10791545 (England and Wales)
Registered Office
The Old Barn
Anchorage Lane, Sprotbrough
Doncaster
South Yorkshire
DN5 8DT
Accountants
Campbell and Stenton Accountancy
17 Bridgegate
Howden
East Yorkshire
DN14 7AE
Unium Bioscience Ltd
Accountants' report
Accountants' report to the board of directors of Unium Bioscience Ltd on the preparation of the unaudited statutory accounts for the year ended 31 December 2024
In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the accounts of
Unium Bioscience Ltd for the year ended
31 December 2024 as set out on pages
5 -
7 from the company's accounting records and from information and explanations you have given us.
This report is made solely to the Board of Directors of Unium Bioscience Ltd, as a body, in accordance with the terms of our engagement. Our work has been undertaken solely to prepare for your approval the accounts of Unium Bioscience Ltd and state those matters that we have agreed to state to them, as a body, in this report. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Unium Bioscience Ltd and its Board of Directors as a body for our work or for this report.
It is your duty to ensure that Unium Bioscience Ltd has kept adequate accounting records and to prepare statutory accounts that give a true and fair view of the assets, liabilities, financial position and profit of Unium Bioscience Ltd. You consider that Unium Bioscience Ltd is exempt from the statutory audit requirement for the year.
We have not been instructed to carry out an audit or a review of the accounts of Unium Bioscience Ltd. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory accounts.
Campbell and Stenton Accountancy
17 Bridgegate
Howden
East Yorkshire
DN14 7AE
15 August 2025
Unium Bioscience Ltd
Statement of financial position
as at 31 December 2024
Intangible assets
3,110
3,110
Tangible assets
3,400
5,174
Inventories
966,421
813,918
Cash at bank and in hand
199,380
292,878
Creditors: amounts falling due within one year
(2,000,027)
(1,264,051)
Net current assets/(liabilities)
228,924
(29,083)
Net assets/(liabilities)
236,449
(19,784)
Called up share capital
150,100
150,100
Profit and loss account
86,349
(169,884)
Shareholders' funds
236,449
(19,784)
For the year ending 31 December 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
The members have agreed to the preparation of abridged accounts for the year in accordance with Section 444(2A).
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board of Directors and authorised for issue on 15 August 2025 and were signed on its behalf by
Mr John Haywood
Director
Company Registration No. 10791545
Unium Bioscience Ltd
Notes to the Accounts
for the year ended 31 December 2024
Unium Bioscience Ltd is a private company, limited by shares, registered in England and Wales, registration number 10791545. The registered office is The Old Barn, Anchorage Lane, Sprotbrough, Doncaster, South Yorkshire, DN5 8DT.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
The accounts are presented in £ sterling.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
Plant & machinery
25% reducing balance
Computer equipment
40% reducing balance
Other tangible fixed assets
0%
Intangible fixed assets (including purchased goodwill and patents) are included at cost less accumulated amortisation.
4
Intangible fixed assets
Total
Unium Bioscience Ltd
Notes to the Accounts
for the year ended 31 December 2024
5
Tangible fixed assets
Total
At 31 December 2024
16,114
At 31 December 2024
12,714
6
Average number of employees
During the year the average number of employees was 2 (2023: 2).